Evidence map›Paper›PMID 31951771›Full record

Trial reportHuman vaccines & immunotherapeutics2020

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01

Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans and 17 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. In-silico analysis of potent Mosquirix vaccine adjuvant leads.Journal, genetic engineering & biotechnology · 2023
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 3 institutions in 2 countries.

Innocent ValéaUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Samuel AdjeiSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Effua UsufVaccine, GSK , Wavre, Belgium.ORCID 0000-0002-6515-7186
Ousmane TraoreUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Daniel AnsongSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Halidou TintoUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Harry Owusu BoatengSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Athanase Mwinessobaonfou SomeUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Patrick BuabengSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Johan VekemansVaccine, GSK , Wavre, Belgium.
Amos KoteySchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Pascale VandoolaegheVaccine, GSK , Wavre, Belgium.
Mark CullinaneVaccine, GSK , Wavre, Belgium.
Magali TraskineVaccine, GSK , Wavre, Belgium.
Florence OuedraogoUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
David SambianSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Marc LievensVaccine, GSK , Wavre, Belgium.
Marc Christian TahitaUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Erik JongertVaccine, GSK , Wavre, Belgium.
Palpouguini LompoUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Ali IdrissSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Dorota BorysVaccine, GSK , Wavre, Belgium.
Sayouba OuedraogoUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Frank PrempehSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Lode SchuermanVaccine, GSK , Wavre, Belgium.
Hermann SorghoUnité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé , Nanoro, Burkina Faso.
Tsiri AgbenyegaSchool of Medical Sciences, KNUST (Agogo Presbyterian Hospital) , Kumasi, Ghana.
Kwame Nkrumah University of Science and Technology · GHInstitut de Recherche en Sciences de la Santé · BFCentre Muraz · BF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RTS,S/AS01

Indexed as

Diphtheria-Tetanus-acellular Pertussis VaccinesHaemophilus VaccinesHepatitis BMalaria VaccinesChildDiphtheria-Tetanus-Pertussis VaccineHepatitis B VaccinesHumansImmunization, SecondaryImmunogenicity, VaccineImmunologic MemoryInfantPoliovirus Vaccine, InactivatedVaccines, CombinedDiphtheria-Tetanus-acellular Pertussis VaccinesDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesHepatitis B VaccinesMalaria VaccinesPoliovirus Vaccine, InactivatedVaccines, CombinedExpanded Program on Immunizationhepatitis Blong-term immunogenicityMalariaRTSsafetyS/AS01Evaccine

Identifiers

PMID31951771
PMCPMC7482624
OpenAlexW3000402950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.